Track Iambic Therapeutics's current cash ($250M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Iambic Therapeutics (IAM) currently reports a current cash of $250M as of September 2026. Use the charts on this page to explore Iambic Therapeutics's current cash history and peer comparisons.
Iambic Therapeutics reported $250M in current cash as of September 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iambic Therapeutics, and consider following IAM for alerts when major investors trade the stock.